Innoget© 2018 Innoget

Showing all visible results for Medicine, Human Health

A seminatural ingredient drug for triglcyeride lowering

A drug combination of 3 USA Generally Regarded as Safe (GRAS), seminatural ingredients is proposed for lowering plasma triglyceride (TG) readings (US and international patents pending). The ingredients are diet components, bu

Investment Opportunities in Startups and Spinoffs

A seminatural ingredient drug for triglcyeride lowering
  • +1 week
  • Hide post

Method for the detection of infective viral particles of SARS-COV2 (COVID-19)

The SARS-CoV-2 detection technique allows us to know the genetic material of the virus, that is, whether or not it is present in the body. The microbiologist David Rodríguez Lázaro, from the University of Burgos, has develo

Patents for licensing

Method for the detection of infective viral particles of SARS-COV2 (COVID-19)
  • +1 week
  • Hide post

Method for manufacturing braided fiber reinforced composite dental posts

An economic, fast, and high-performance method for manufacturing FRC dental posts has been developed. The resulting product is suitable for its use in dentistry and solves the two main problems in the existing manufacturing p

Patents for licensing

Method for manufacturing braided fiber reinforced composite dental posts
  • +2 weeks
  • Hide post

Novel Antimicrobial Based on Control-Release Iodine

A novel class of iodine technology has been developed producing iodophors in many product forms that control release iodine in minute, biocompatible quantities resulting in sanitizing products with superior biocidal efficacy,

Innovative Products and Technologies

  • +2 weeks
  • Hide post

New COVID-19 Screening Method

The early and efficient detection of COVID-19 cases remains an unresolved issue. The detection of cases affected by COVID-19 is based on symptoms or contact tracing. But 60% of COVID-19 cases are asymptomatic or have few and

Patents for licensing

New COVID-19 Screening Method
  • +2 months
  • Hide post

In vitro method for detecting tumor growth and diagnosing or prognosticating the risk of metastasis in a human subject that has been diagnosed with uveal melanoma

Problem to solve: Uveal ocular melanoma is the most common primary ocular malignancy in adults, with an incidence of approximately 7 cases per million inhabitants per year. Its incidence is therefore not very high, but it

Patents for licensing

In vitro method for detecting tumor growth and diagnosing or prognosticating the risk of metastasis in a human subject that has been diagnosed with uveal melanoma
  • +2 months
  • Hide post

A simultaneous detection system of chromosomal alterations by sequencing, cytometry and imaging

New in vitro method to evaluate the presence of chromosomal alterations, particularly in 17q25. That applies three techniques combined (magnetic capture, flow cytometry and microscopy techniques) using a single specific DNA-l

Patents for licensing

A simultaneous detection system of chromosomal alterations by sequencing, cytometry and imaging
  • +2 months
  • Hide post

Pressure gauge plunger for 3D printing platforms.

Pressure measuring device for 3D printing platforms. This device is applicable to various fields using the extrusion of semi-solid masses (tissue bioprinting, food industry, pharmaceutical, ceramics). Its usefulness lies in t

Patents for licensing

  • +2 months
  • Hide post

Biomarkers for the diagnosis of pediatric B-cell acute lymphoblastic leukemia (B-ALL).

The present invention highlights the identification of two new biomarkers for the diagnosis of pediatric B-cell acute lymphoblastic leukemia (B-ALL). In this sense, the analysis of the expression of the lncRNA and mRNA pair m

Patents for licensing

Biomarkers for the diagnosis of pediatric B-cell acute lymphoblastic leukemia (B-ALL).
  • +3 months
  • Hide post

Use of small molecules to rescue folding defective proteins

This invention focuses on favouring the folding of the faulty protein by using molecules known as CFTR (Cystic fibrosis transmembrane conductance regulator) correctors, already selected for the treatment of cystic fibrosis.

Patents for licensing

Use of small molecules to rescue folding defective proteins
  • +3 months
  • Hide post

Living cell system of marine mammals for cell biology studies, toxicological tests and large-scale research application

The technology of S.S.S. consists in its being an "Integrated System", it allows to perform studies in multiple combinations between the 5 cell lines of the kit, giving the possibility to obtain species-specific biological re

Patents for licensing

Living cell system of marine mammals for cell biology studies, toxicological tests and large-scale research application
  • +3 months
  • Hide post

SerpinB3 inhibitor for tumor treatment

The compound 1-piperidin propionic acid, inhibitor of SerpinB3 production, is proposed as a novel adjuvant drug in the treatment of different types of solid tumors resistant to chemotherapy.

Patents for licensing

SerpinB3 inhibitor for tumor treatment
  • +3 months
  • Hide post

Matrices for in vitro tumor tissues allow to test antineoplastic drugs and protocols

Disclosed is a 3D matrices for in vitro growth of tumor tissues. Recreating a good model of tumor tissue in vitro allows you to experiment with new formulation anti-neoplastic drugs, to develop the optimal conditions of elec

Patents for licensing

Matrices for in vitro tumor tissues allow to test antineoplastic drugs and protocols
  • +3 months
  • Hide post

Myeloid leukemia treatment with tioridazina analogues

The invention relates to new thioridazine analogue compounds as a treatment for acute myeloid leukemia. In particular, the compounds show high cytotoxic activity on pediatric acute myeloid leukemia (AML) cells harboring a spe

Patents for licensing

Myeloid leukemia treatment with tioridazina analogues
  • +3 months
  • Hide post

A small molecule inhibitor of OPA1 GTPase activity with anti-cancer properties

The invention belongs to the field of research to improve the treatment of disorders such as cancer and cancer-induced angiogenesis involving the upregulation of the levels of the said protein OPA1.

Patents for licensing

A small molecule inhibitor of OPA1 GTPase activity with anti-cancer properties
  • +3 months
  • Hide post